ClinicalTrials.Veeva

Menu

Extracellular Vesicles as Biomarkers for Chronic Renal Failure (VE-IRC)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Chronic Renal Failure
Urinary Extracellular Vesicle

Treatments

Diagnostic Test: urinary extracellular vesicle concentration
Diagnostic Test: blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT04700631
PI2020_843_0104

Details and patient eligibility

About

The recent discovery of extracellular vesicles (EV) as a mechanism of intercellular communication has made it possible to develop a new field of health research and could bring new information on the pathological mechanisms of renal diseases. Definition of physiologic and pathologic values of urinary extracellular vesicles (EVu) between healthy subjects and chronic kidney diseases (CKD) patients could be a new tool for follow up of renal diseases. EV are found in all biological fluids including urine, that's why they are increasingly analyzed in renal pathologies. The main objective of this study is to determine the physiological values and the pathological thresholds of EVu.

Enrollment

143 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • subject > 18 years old
  • healthy subjects : no medical history, in particular cardiovascular, without drug treatment, without proteinuria, normal BMI
  • CRF patients : eGFR estimated according to the MRDR formula less than 89 mL/min/1,73m²

Exclusion criteria

  • patients under dialysis protocols
  • renal transplant patients

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

143 participants in 2 patient groups

healthy subject
Active Comparator group
Description:
healthy subjects : no medical history, in particular cardiovascular, without drug treatment, without proteinuria, normal BMI
Treatment:
Diagnostic Test: blood sample
Diagnostic Test: urinary extracellular vesicle concentration
CRF patients
Experimental group
Description:
CRF patients : eGFR estimated according to the MRDR formula less than 89 mL/min/1,73m²
Treatment:
Diagnostic Test: blood sample
Diagnostic Test: urinary extracellular vesicle concentration

Trial contacts and locations

1

Loading...

Central trial contact

Claire PRESNE, MD; Nicolas GUILLAUME, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems